B-CELL LYMPHOMA LACKING FC- AND C3D-RECEPTORSTHIEL E.1978; BLUT; DEU; DA. 1978; VOL. 37; NO 6; PP. 307-312; ABS. GER; BIBL. 23 REF.Article

Vaccin reconstituant contre l'hépatite virale B. Influence de l'antigène de surface HBS sur le complément C3 et C5MAKI, E; NAGAMI, K; MOTEGI, K et al.Yakuri to chiryo. 1987, Vol 15, Num 6, pp 71-77, issn 0386-3603Article

Immunoglobulin production by human peripheral lymphocytes induced by anti-C3 receptor antibodiesDAHA, M. R; BLOEM, A. C; BALLIEUX, R. E et al.The Journal of immunology (1950). 1984, Vol 132, Num 3, pp 1197-1201, issn 0022-1767Article

FACTOR B OF THE ALTERNATIVE COMPLEMENT PATHWAY ON HUMAN LYMPHOCYTES.HALBWACHS L; LACHMANN PJ.1976; SCAND. J. IMMUNOL.; NORWAY; DA. 1976; VOL. 5; NO 6-7; PP. 697-704; BIBL. 31 REF.Article

Deposition and degradation of C3 on type III group B streptococciCAMPBELL, J. R; BAKER, C. J; EDWARDS, M. S et al.Infection and immunity. 1991, Vol 59, Num 6, pp 1978-1983, issn 0019-9567, 6 p.Article

THE GENERATION OF MEMORY CELLS. I. THE ROLE OF C³ IN THE GENERATION OF B MEMORY CELLS.KLAUS GGB; HUMPHREY JH.1977; IMMUNOLOGY; G.B.; DA. 1977; VOL. 33; NO 1; PP. 31-40; BIBL. 24 REF.Article

STUDIES ON THE MECHANISM OF THE COMPLEMENT-MEDIATED INHIBITION OF THE FC AND C3 RECEPTORS OF B LYMPHOCYTES.ERDEI A; FUST G; SARMAY G et al.1977; CLIN. IMMUNOL. IMMUNOPATHOL.; U.S.A.; DA. 1977; VOL. 8; NO 3; PP. 367-376; BIBL. 29 REF.Article

C3-REACTED SEPHAROSE: A PREPARATIVE METHOD FOR SEPARATING T AND B LYMPHOCYTES.CASALI P; PERUSSIA BM.1977; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1977; VOL. 27; NO 1; PP. 38-42; BIBL. 17 REF.Article

ANDAMENTO E RAPPORTI TRA ANTIGENE B DI SUPERFICIE (HBSAG) 3^A FRAZIONE DEL COMPLEMENTO (C₃) E FOSFOESOSOISOMERASI (P.H.I.) NELL' EPATITE ACUTA = TAUX ET RELATIONS ENTRE L'ANTIGENE DE SURFACE DE L'HEPATITE B (HBSAG), LA TROISIEME FRACTION DU COMPLEMENT (C₃) ET LA PHOSPHOHEXOSE ISOMERASE (P.H.I.) LORS D'UNE HEPATITE AIGUEFIORI GP; ORSI PG; POGGIO A et al.1980; G. MAL. INFETT. PARASSIT.; ISSN 0017-0321; ITA; DA. 1980; VOL. 32; NO 11; PP. 963-966; ABS. ENG; BIBL. 13 REF.Article

BINDING OF COMPONENTS OF THE PROPERDIN SYSTEM TO CULTURED HUMAN LYMPHOBLASTOID CELLS AND B LYMPHOCYTES = FIXATION DE COMPOSANTS DU SYSTEME PROPERDINE A DES CELLULES LYMPHOBLASTOIDES HUMAINES CULTIVEES ET A DES LYMPHOCYTES BTHEOFILOPOULOS AN; PERRIN LH.1976; J. EXPER. MED.; U.S.A.; DA. 1976; VOL. 143; NO 2; PP. 271-289; BIBL. 3 P.Article

A reexamination of the role of magnesium in the human alternative pathway of complementPRYZDIAL, E. L. G; ISENMAN, D. E.Molecular immunology. 1986, Vol 23, Num 1, pp 87-96, issn 0161-5890Article

The role of C3 in mediating binding and ingestion of group B streptococcus serotype III by murine macrophagesNOEL, G. J; KATZ, S. L; EDELSON, P. J et al.Pediatric research. 1991, Vol 30, Num 1, pp 118-123, issn 0031-3998Article

Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytesMOORE, M. D; COOPER, N. R; TACK, B. F et al.Proceedings of the National Academy of Sciences of the United States of America. 1987, Vol 84, Num 24, pp 9194-9198, issn 0027-8424Article

Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibodyTEDDER, T. F; CLEMENT, L. T; COOPER, M. D et al.The Journal of immunology (1950). 1984, Vol 133, Num 2, pp 678-683, issn 0022-1767Article

Two modes of homologous C3 deposition on Ramos Burkitt's lymphoma cell substrains co-expressing DAF (CD55), CD59, and CR2 (CD21), and on cells lacking themSEYA, T; HARA, T; OKADA, M et al.International immunology. 1992, Vol 4, Num 12, pp 1361-1371, issn 0953-8178Article

Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21)ESPARZA, I; BECHERER, J. D; ALSENZ, J et al.European journal of immunology. 1991, Vol 21, Num 11, pp 2829-2838, issn 0014-2980Article

Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2)NEMEROW, G. R; WOLFERT, R; MCNAUGHTON, M. E et al.Journal of virology. 1985, Vol 55, Num 2, pp 347-351, issn 0022-538XArticle

Immunologic subsets in B cell lymphomas defined by surface immunoglobulin isotype and complement receptor ― Their relationship to survivalKVALØY, S; LANGHOLM, R; KAALHUS, O et al.Scandinavian journal of haematology. 1985, Vol 35, Num 2, pp 137-144, issn 0036-553XArticle

Monoclonal antibodies to the 140,000 mol wt glycoprotein of B lymphocyte membranes (CR2 receptor) initiates proliferation of B cells in vitroWILSON, B. S; PLATT, J. L; KAY, N. E et al.Blood. 1985, Vol 66, Num 4, pp 824-829, issn 0006-4971Article

The identification of N-linked oligosaccharides on the human CR2/Epstein-Barr virus receptor and their function in receptor metabolism, plasma membrane expression, and ligand bindingWEIS, J. J; FEARON, D. T.The Journal of biological chemistry (Print). 1985, Vol 260, Num 25, pp 13824-13830, issn 0021-9258Article

A 16 amino-acid synthetic peptide, derived from human C3d, carries regulatory activity on in vitro phosphorylation of a cellular component of the human lymphoma cells, RajiLYAMANI, F; GAUFFRE, A; BAREL, M et al.Biochemical and biophysical research communications (Print). 1991, Vol 175, Num 3, pp 823-830, issn 0006-291X, 8 p.Article

C3d-mediated negative and positive signals on the proliferation of human B cells separated from bloodKURAYA, M; NILSSON, B; NILSSON-EKDAHL, K et al.Immunology letters. 1990, Vol 26, Num 1, pp 51-58, issn 0165-2478, 8 p.Article

gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptorFRADE, R; BAREL, M; EHLIN-HENRIKSSON, B et al.Proceedings of the National Academy of Sciences of the United States of America. 1985, Vol 82, Num 5, pp 1490-1493, issn 0027-8424Article

Comparison of peripheral blood lymphocyte C3 receptor capping properties in patients with chronic lymphocytic leukemia and lymphomaHENDRICK, A. M; GORMUS, B. J; LEECH, S. H et al.Cancer. 1985, Vol 56, Num 7, pp 1538-1542, issn 0008-543XArticle

Ontogenical studies on kinetics of lipopolysaccharide-induced response to bromelain-treated mouse erythrocytes in mouse spleen cells. II: Response of spleen cells with or without Fc receptors, C3 receptors, or Ia antigensKAWAGUCHI, S.Cellular immunology (Print). 1985, Vol 94, Num 1, pp 60-72, issn 0008-8749Article